These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 10397275)

  • 21. Characterization and tumorigenicity of human ovarian surface epithelial cells immortalized by SV40 large T antigen.
    Nitta M; Katabuchi H; Ohtake H; Tashiro H; Yamaizumi M; Okamura H
    Gynecol Oncol; 2001 Apr; 81(1):10-7. PubMed ID: 11277643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.
    Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Risch HA; Puopolo M; Yu H
    Clin Cancer Res; 2006 Feb; 12(4):1208-14. PubMed ID: 16489075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-like growth factor-1 and its receptor mediate the autocrine proliferation of human ovarian carcinoma cell lines.
    Resnicoff M; Ambrose D; Coppola D; Rubin R
    Lab Invest; 1993 Dec; 69(6):756-60. PubMed ID: 8264238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
    Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
    Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells.
    Fang J; Zhou Q; Shi XL; Jiang BH
    Carcinogenesis; 2007 Mar; 28(3):713-23. PubMed ID: 17065200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor.
    Resnicoff M; Coppola D; Sell C; Rubin R; Ferrone S; Baserga R
    Cancer Res; 1994 Sep; 54(18):4848-50. PubMed ID: 8069850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockage of IGF-1R signaling sensitizes urinary bladder cancer cells to mitomycin-mediated cytotoxicity.
    Sun HZ; Wu SF; Tu ZH
    Cell Res; 2001 Jun; 11(2):107-15. PubMed ID: 11453542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of insulin-like growth factor-1 and insulin-like growth factor-1 receptors in EL4 lymphoma cells overexpressing growth hormone.
    Weigent DA; Arnold RE
    Cell Immunol; 2005 Mar; 234(1):54-66. PubMed ID: 15964559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Suppression of insulin-like growth factor-1 receptor by RNA interference inhibits cell growth in vitro and induces chemosensitization of HO8910PM cell to cisplatin].
    Gao H; Shi J; Ge SF; DI W
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):45-9. PubMed ID: 18366933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo.
    Chernicky CL; Yi L; Tan H; Gan SU; Ilan J
    Cancer Gene Ther; 2000 Mar; 7(3):384-95. PubMed ID: 10766344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth regulation of human glioblastoma T98G cells by insulin-like growth factor-1 and its receptor.
    Ambrose D; Resnicoff M; Coppola D; Sell C; Miura M; Jameson S; Baserga R; Rubin R
    J Cell Physiol; 1994 Apr; 159(1):92-100. PubMed ID: 8138595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871.
    Cohen BD; Baker DA; Soderstrom C; Tkalcevic G; Rossi AM; Miller PE; Tengowski MW; Wang F; Gualberto A; Beebe JS; Moyer JD
    Clin Cancer Res; 2005 Mar; 11(5):2063-73. PubMed ID: 15756033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of antisense survivin RNA transfection on the growth of ovarian carcinoma SKOV3 cells in vitro and in vivo].
    Shi HR; Lan L; Qiao YH; Li KH; Hou LJ; Liu HX
    Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):831-5. PubMed ID: 16412330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of macrophage colony-stimulating factor (CSF-1) and its receptor, c-fms, in normal ovarian granulosa cells leads to cell proliferation and tumorigenesis.
    Keshava N; Gubba S; Tekmal RR
    J Soc Gynecol Investig; 1999; 6(1):41-9. PubMed ID: 10065425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual silencing of type 1 insulin-like growth factor and epidermal growth factor receptors to induce apoptosis of nasopharyngeal cancer cells.
    Yuan YL; Zhou XH; Song J; Qiu XP; Li J; Ye LF
    J Laryngol Otol; 2008 Sep; 122(9):952-60. PubMed ID: 17908353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomerase prolongs the lifespan of normal human ovarian surface epithelial cells without inducing neoplastic phenotype.
    Alvero AB; Fishman DA; Qumsiyeh MB; Garg M; Kacinski BM; Sapi E
    J Soc Gynecol Investig; 2004 Dec; 11(8):553-61. PubMed ID: 15582501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor 1 receptor activates c-SRC and modifies transformation and motility of colon cancer in vitro.
    Sekharam M; Nasir A; Kaiser HE; Coppola D
    Anticancer Res; 2003; 23(2B):1517-24. PubMed ID: 12820418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
    Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D
    Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo antitumor activity and induction of insulin-like growth factor-1-resistant apoptosis by SC-alphaalphadelta9.
    Vogt A; Wang AS; Johnson CS; Fabisiak JP; Wipf P; Lazo JS
    J Pharmacol Exp Ther; 2000 Feb; 292(2):530-7. PubMed ID: 10640289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.